Serveur d'exploration sur le LRGP

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism

Identifieur interne : 000B91 ( PascalFrancis/Corpus ); précédent : 000B90; suivant : 000B92

Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism

Auteurs : S. Oerther ; H. Le Gall ; E. Payan ; Francois Lapicque ; N. Presle ; P. Hubert ; J. Dexheimer ; P. Netter ; Francoise Lapicque

Source :

RBID : Pascal:99-0265579

Descripteurs français

English descriptors

Abstract

With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL. The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate.

Notice en format standard (ISO 2709)

Pour connaître la documentation sur le format Inist Standard.

pA  
A01 01  1    @0 0006-3592
A02 01      @0 BIBIAU
A03   1    @0 Biotechnol. bioeng.
A05       @2 63
A06       @2 2
A08 01  1  ENG  @1 Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism
A11 01  1    @1 OERTHER (S.)
A11 02  1    @1 LE GALL (H.)
A11 03  1    @1 PAYAN (E.)
A11 04  1    @1 LAPICQUE (Francois)
A11 05  1    @1 PRESLE (N.)
A11 06  1    @1 HUBERT (P.)
A11 07  1    @1 DEXHEIMER (J.)
A11 08  1    @1 NETTER (P.)
A11 09  1    @1 LAPICQUE (Francoise)
A14 01      @1 Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184 @2 54505 Vandoeuvre les Nancy @3 FRA @Z 1 aut. @Z 3 aut. @Z 5 aut. @Z 8 aut. @Z 9 aut.
A14 02      @1 Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451 @2 54001 Nancy @3 FRA @Z 2 aut. @Z 4 aut.
A14 03      @1 UMR 7568 CNRS-INPL & FR CNRS W0070, ENSIC-INPL, BP 451 @2 54001 Nancy @3 FRA @Z 6 aut.
A14 04      @1 Laboratoire de Biologie Forestière, Faculté des Sciences, UHP, Nancy 1, BP 239 @2 54506 Vandoeuvre les Nancy @3 FRA @Z 7 aut.
A20       @1 206-215
A21       @1 1999
A23 01      @0 ENG
A43 01      @1 INIST @2 9164 @5 354000073846140090
A44       @0 0000 @1 © 1999 INIST-CNRS. All rights reserved.
A45       @0 33 ref.
A47 01  1    @0 99-0265579
A60       @1 P
A61       @0 A
A64 01  1    @0 Biotechnology and bioengineering
A66 01      @0 USA
C01 01    ENG  @0 With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL. The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate.
C02 01  X    @0 001D09C04
C03 01  X  FRE  @0 Biomatériau @5 01
C03 01  X  ENG  @0 Biomaterial @5 01
C03 01  X  SPA  @0 Biomaterial @5 01
C03 02  X  FRE  @0 Gel @5 02
C03 02  X  ENG  @0 Freeze @5 02
C03 02  X  SPA  @0 Helada @5 02
C03 03  X  FRE  @0 Hyaluronique acide @2 NK @5 10
C03 03  X  ENG  @0 Hyaluronic acid @2 NK @5 10
C03 03  X  SPA  @0 Hialurónico ácido @2 NK @5 10
C03 04  X  FRE  @0 Propriété rhéologique @5 11
C03 04  X  ENG  @0 Rheological properties @5 11
C03 04  X  SPA  @0 Propiedad rheológica @5 11
C03 05  X  FRE  @0 Processus diffusion @5 12
C03 05  X  ENG  @0 Diffusion process @5 12
C03 05  X  SPA  @0 Proceso difusión @5 12
C03 06  X  FRE  @0 Application industrielle @5 19
C03 06  X  ENG  @0 Industrial application @5 19
C03 06  X  SPA  @0 Aplicación industrial @5 19
C03 07  X  FRE  @0 Industrie pharmaceutique @5 21
C03 07  X  ENG  @0 Pharmaceutical industry @5 21
C03 07  X  SPA  @0 Industria farmacéutica @5 21
C03 08  X  FRE  @0 Application médicale @5 35
C03 08  X  ENG  @0 Medical application @5 35
C03 08  X  SPA  @0 Aplicación medical @5 35
C03 09  X  FRE  @0 Alginate @5 53
C03 09  X  ENG  @0 Alginates @5 53
C03 09  X  SPA  @0 Alginato @5 53
N21       @1 165

Format Inist (serveur)

NO : PASCAL 99-0265579 INIST
ET : Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism
AU : OERTHER (S.); LE GALL (H.); PAYAN (E.); LAPICQUE (Francois); PRESLE (N.); HUBERT (P.); DEXHEIMER (J.); NETTER (P.); LAPICQUE (Francoise)
AF : Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184/54505 Vandoeuvre les Nancy/France (1 aut., 3 aut., 5 aut., 8 aut., 9 aut.); Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451/54001 Nancy/France (2 aut., 4 aut.); UMR 7568 CNRS-INPL & FR CNRS W0070, ENSIC-INPL, BP 451/54001 Nancy/France (6 aut.); Laboratoire de Biologie Forestière, Faculté des Sciences, UHP, Nancy 1, BP 239/54506 Vandoeuvre les Nancy/France (7 aut.)
DT : Publication en série; Niveau analytique
SO : Biotechnology and bioengineering; ISSN 0006-3592; Coden BIBIAU; Etats-Unis; Da. 1999; Vol. 63; No. 2; Pp. 206-215; Bibl. 33 ref.
LA : Anglais
EA : With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL. The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate.
CC : 001D09C04
FD : Biomatériau; Gel; Hyaluronique acide; Propriété rhéologique; Processus diffusion; Application industrielle; Industrie pharmaceutique; Application médicale; Alginate
ED : Biomaterial; Freeze; Hyaluronic acid; Rheological properties; Diffusion process; Industrial application; Pharmaceutical industry; Medical application; Alginates
SD : Biomaterial; Helada; Hialurónico ácido; Propiedad rheológica; Proceso difusión; Aplicación industrial; Industria farmacéutica; Aplicación medical; Alginato
LO : INIST-9164.354000073846140090
ID : 99-0265579

Links to Exploration step

Pascal:99-0265579

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism</title>
<author>
<name sortKey="Oerther, S" sort="Oerther, S" uniqKey="Oerther S" first="S." last="Oerther">S. Oerther</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Le Gall, H" sort="Le Gall, H" uniqKey="Le Gall H" first="H." last="Le Gall">H. Le Gall</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Payan, E" sort="Payan, E" uniqKey="Payan E" first="E." last="Payan">E. Payan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lapicque, Francois" sort="Lapicque, Francois" uniqKey="Lapicque F" first="Francois" last="Lapicque">Francois Lapicque</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Presle, N" sort="Presle, N" uniqKey="Presle N" first="N." last="Presle">N. Presle</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hubert, P" sort="Hubert, P" uniqKey="Hubert P" first="P." last="Hubert">P. Hubert</name>
<affiliation>
<inist:fA14 i1="03">
<s1>UMR 7568 CNRS-INPL & FR CNRS W0070, ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Dexheimer, J" sort="Dexheimer, J" uniqKey="Dexheimer J" first="J." last="Dexheimer">J. Dexheimer</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Laboratoire de Biologie Forestière, Faculté des Sciences, UHP, Nancy 1, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Netter, P" sort="Netter, P" uniqKey="Netter P" first="P." last="Netter">P. Netter</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lapicque, Francoise" sort="Lapicque, Francoise" uniqKey="Lapicque F" first="Francoise" last="Lapicque">Francoise Lapicque</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">99-0265579</idno>
<date when="1999">1999</date>
<idno type="stanalyst">PASCAL 99-0265579 INIST</idno>
<idno type="RBID">Pascal:99-0265579</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000B91</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism</title>
<author>
<name sortKey="Oerther, S" sort="Oerther, S" uniqKey="Oerther S" first="S." last="Oerther">S. Oerther</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Le Gall, H" sort="Le Gall, H" uniqKey="Le Gall H" first="H." last="Le Gall">H. Le Gall</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Payan, E" sort="Payan, E" uniqKey="Payan E" first="E." last="Payan">E. Payan</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lapicque, Francois" sort="Lapicque, Francois" uniqKey="Lapicque F" first="Francois" last="Lapicque">Francois Lapicque</name>
<affiliation>
<inist:fA14 i1="02">
<s1>Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Presle, N" sort="Presle, N" uniqKey="Presle N" first="N." last="Presle">N. Presle</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Hubert, P" sort="Hubert, P" uniqKey="Hubert P" first="P." last="Hubert">P. Hubert</name>
<affiliation>
<inist:fA14 i1="03">
<s1>UMR 7568 CNRS-INPL & FR CNRS W0070, ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Dexheimer, J" sort="Dexheimer, J" uniqKey="Dexheimer J" first="J." last="Dexheimer">J. Dexheimer</name>
<affiliation>
<inist:fA14 i1="04">
<s1>Laboratoire de Biologie Forestière, Faculté des Sciences, UHP, Nancy 1, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Netter, P" sort="Netter, P" uniqKey="Netter P" first="P." last="Netter">P. Netter</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
<author>
<name sortKey="Lapicque, Francoise" sort="Lapicque, Francoise" uniqKey="Lapicque F" first="Francoise" last="Lapicque">Francoise Lapicque</name>
<affiliation>
<inist:fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">Biotechnology and bioengineering</title>
<title level="j" type="abbreviated">Biotechnol. bioeng.</title>
<idno type="ISSN">0006-3592</idno>
<imprint>
<date when="1999">1999</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">Biotechnology and bioengineering</title>
<title level="j" type="abbreviated">Biotechnol. bioeng.</title>
<idno type="ISSN">0006-3592</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alginates</term>
<term>Biomaterial</term>
<term>Diffusion process</term>
<term>Freeze</term>
<term>Hyaluronic acid</term>
<term>Industrial application</term>
<term>Medical application</term>
<term>Pharmaceutical industry</term>
<term>Rheological properties</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Biomatériau</term>
<term>Gel</term>
<term>Hyaluronique acide</term>
<term>Propriété rhéologique</term>
<term>Processus diffusion</term>
<term>Application industrielle</term>
<term>Industrie pharmaceutique</term>
<term>Application médicale</term>
<term>Alginate</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL. The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0006-3592</s0>
</fA01>
<fA02 i1="01">
<s0>BIBIAU</s0>
</fA02>
<fA03 i2="1">
<s0>Biotechnol. bioeng.</s0>
</fA03>
<fA05>
<s2>63</s2>
</fA05>
<fA06>
<s2>2</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>OERTHER (S.)</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>LE GALL (H.)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>PAYAN (E.)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>LAPICQUE (Francois)</s1>
</fA11>
<fA11 i1="05" i2="1">
<s1>PRESLE (N.)</s1>
</fA11>
<fA11 i1="06" i2="1">
<s1>HUBERT (P.)</s1>
</fA11>
<fA11 i1="07" i2="1">
<s1>DEXHEIMER (J.)</s1>
</fA11>
<fA11 i1="08" i2="1">
<s1>NETTER (P.)</s1>
</fA11>
<fA11 i1="09" i2="1">
<s1>LAPICQUE (Francoise)</s1>
</fA11>
<fA14 i1="01">
<s1>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184</s1>
<s2>54505 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>5 aut.</sZ>
<sZ>8 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>UMR 7568 CNRS-INPL & FR CNRS W0070, ENSIC-INPL, BP 451</s1>
<s2>54001 Nancy</s2>
<s3>FRA</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Laboratoire de Biologie Forestière, Faculté des Sciences, UHP, Nancy 1, BP 239</s1>
<s2>54506 Vandoeuvre les Nancy</s2>
<s3>FRA</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA20>
<s1>206-215</s1>
</fA20>
<fA21>
<s1>1999</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>9164</s2>
<s5>354000073846140090</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 1999 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>33 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>99-0265579</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>Biotechnology and bioengineering</s0>
</fA64>
<fA66 i1="01">
<s0>USA</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL. The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>001D09C04</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Biomatériau</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Biomaterial</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Biomaterial</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Gel</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Freeze</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Helada</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Hyaluronique acide</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Hyaluronic acid</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Hialurónico ácido</s0>
<s2>NK</s2>
<s5>10</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Propriété rhéologique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Rheological properties</s0>
<s5>11</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Propiedad rheológica</s0>
<s5>11</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Processus diffusion</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Diffusion process</s0>
<s5>12</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Proceso difusión</s0>
<s5>12</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Application industrielle</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Industrial application</s0>
<s5>19</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Aplicación industrial</s0>
<s5>19</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Industrie pharmaceutique</s0>
<s5>21</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Pharmaceutical industry</s0>
<s5>21</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Industria farmacéutica</s0>
<s5>21</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Application médicale</s0>
<s5>35</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Medical application</s0>
<s5>35</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Aplicación medical</s0>
<s5>35</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Alginate</s0>
<s5>53</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Alginates</s0>
<s5>53</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Alginato</s0>
<s5>53</s5>
</fC03>
<fN21>
<s1>165</s1>
</fN21>
</pA>
</standard>
<server>
<NO>PASCAL 99-0265579 INIST</NO>
<ET>Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism</ET>
<AU>OERTHER (S.); LE GALL (H.); PAYAN (E.); LAPICQUE (Francois); PRESLE (N.); HUBERT (P.); DEXHEIMER (J.); NETTER (P.); LAPICQUE (Francoise)</AU>
<AF>Physiopathologie et Pharmacologie Articulaires, UMR 7561 CNRS-UHP Nancy 1 & FR CNRS W0070, Faculté de Médecine, BP 184/54505 Vandoeuvre les Nancy/France (1 aut., 3 aut., 5 aut., 8 aut., 9 aut.); Laboratoire des Sciences du Génie Chimique, CNRS-ENSIC-INPL, BP 451/54001 Nancy/France (2 aut., 4 aut.); UMR 7568 CNRS-INPL & FR CNRS W0070, ENSIC-INPL, BP 451/54001 Nancy/France (6 aut.); Laboratoire de Biologie Forestière, Faculté des Sciences, UHP, Nancy 1, BP 239/54506 Vandoeuvre les Nancy/France (7 aut.)</AF>
<DT>Publication en série; Niveau analytique</DT>
<SO>Biotechnology and bioengineering; ISSN 0006-3592; Coden BIBIAU; Etats-Unis; Da. 1999; Vol. 63; No. 2; Pp. 206-215; Bibl. 33 ref.</SO>
<LA>Anglais</LA>
<EA>With the aim of producing a biomaterial for surgical applications, the alginate-hyaluronate association has been investigated to combine the gel-forming properties of alginate with the healing properties of hyaluronate. Gels were prepared by diffusion of calcium into alginate-hyaluronate mixtures, with an alginate content of 20 mg/mL. The hyaluronate source was shown to have significant effect on the aspect and the properties of the gels. The gels have viscoelastic behaviour and the transient measurements carried out in creep mode could be interpreted through a Kelvin-Voigt generalised model: experimental data led to the steady state hardness and a characteristic viscosity of the gel. Gels prepared from Na rooster comb hyaluronate with weight ratio up to 0.50 have satisfactory mechanical properties, and fully stable gels are obtained after a few days; on the contrary, use of lower molecular weight hyaluronate led to loose gels for hyaluronate contents over 0.25. Gel formation was investigated by measurements of the exchange fluxes between the calcium chloride solution and the forming gel, which allowed thorough investigations of the occuring diffusion phenomena of water, calcium ion and hyaluronate. Strong interactions of water with hyaluronate reduce significantly the rate of weight loss from the gel beads and allows higher water content in steady-state gels. Calcium content in the gel samples could be correlated to the actual alginate concentration, whatever the nature and the weight ratio of hyaluronate.</EA>
<CC>001D09C04</CC>
<FD>Biomatériau; Gel; Hyaluronique acide; Propriété rhéologique; Processus diffusion; Application industrielle; Industrie pharmaceutique; Application médicale; Alginate</FD>
<ED>Biomaterial; Freeze; Hyaluronic acid; Rheological properties; Diffusion process; Industrial application; Pharmaceutical industry; Medical application; Alginates</ED>
<SD>Biomaterial; Helada; Hialurónico ácido; Propiedad rheológica; Proceso difusión; Aplicación industrial; Industria farmacéutica; Aplicación medical; Alginato</SD>
<LO>INIST-9164.354000073846140090</LO>
<ID>99-0265579</ID>
</server>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Lorraine/explor/LrgpV1/Data/PascalFrancis/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000B91 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Corpus/biblio.hfd -nk 000B91 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Lorraine
   |area=    LrgpV1
   |flux=    PascalFrancis
   |étape=   Corpus
   |type=    RBID
   |clé=     Pascal:99-0265579
   |texte=   Hyaluronate-alginate gel as a novel biomaterial : Mechanical properties and formation mechanism
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Sat Nov 11 15:47:48 2017. Site generation: Wed Mar 6 23:31:34 2024